Tadalafil is a PDE5 inhibitor. Tadalafil’s pharmacologic distinction is its longer half-life of 17.50 hours. Tadegra is indicated for the treatment of men with erectile dysfunction (ED), men with the signs and symptoms of benign prostatic hyperplasia (BPH), and men with both ED and the signs and symptoms of BPH. Tadegra is not indicated for women or children.
Tadalafil 10 mg. / 20 mg. Tab.